Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5658487 | Gastroenterology | 2017 | 42 Pages |
Abstract
Patients with SAH given prednisolone are at greater risk for developing serious infections and infections after treatment than patients not given prednisolone, which may offset its therapeutic benefit. Level of circulating bDNA before treatment could identify patients at high risk of infection if given prednisolone; these data could be used to select therapies for patients with SAH. EudraCT no: 2009-013897-42; Current Controlled Trials no: ISRCTN88782125.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Nikhil Vergis, Stephen R. Atkinson, Suzanne Knapp, James Maurice, Michael Allison, Andrew Austin, Ewan H. Forrest, Steven Masson, Anne McCune, David Patch, Paul Richardson, Dermot Gleeson, Stephen D. Ryder, Mark Wright, Mark R. Thursz,